Erica B. Esrick

2.0k total citations
24 papers, 560 citations indexed

About

Erica B. Esrick is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Erica B. Esrick has authored 24 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 12 papers in Hematology and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Erica B. Esrick's work include Hemoglobinopathies and Related Disorders (16 papers), Prenatal Screening and Diagnostics (9 papers) and Iron Metabolism and Disorders (7 papers). Erica B. Esrick is often cited by papers focused on Hemoglobinopathies and Related Disorders (16 papers), Prenatal Screening and Diagnostics (9 papers) and Iron Metabolism and Disorders (7 papers). Erica B. Esrick collaborates with scholars based in United States, France and United Kingdom. Erica B. Esrick's co-authors include Benjamin L. Ebert, Vijay G. Sankaran, Stuart H. Orkin, Jian Xu, Zhen Shao, Gregory C. Ippolito, Philip W. Tucker, Cong Peng, Yuko Fujiwara and David A. Williams and has published in prestigious journals such as Science, Nature Medicine and Nature Communications.

In The Last Decade

Erica B. Esrick

23 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erica B. Esrick United States 11 351 290 204 142 95 24 560
Thipparat Suwanmanee United States 9 65 0.2× 281 1.0× 59 0.3× 26 0.2× 146 1.5× 10 399
Paola Tonucci Italy 7 382 1.1× 113 0.4× 330 1.6× 140 1.0× 52 0.5× 8 539
Barnaby Clark United Kingdom 9 194 0.6× 66 0.2× 159 0.8× 62 0.4× 65 0.7× 23 323
Manuela Tumino Italy 12 51 0.1× 103 0.4× 68 0.3× 57 0.4× 48 0.5× 23 308
Mary Link United States 4 309 0.9× 101 0.3× 232 1.1× 178 1.3× 54 0.6× 8 445
Chutima Kumkhaek United States 13 257 0.7× 160 0.6× 205 1.0× 59 0.4× 49 0.5× 25 457
J. Kurtzberg United States 3 273 0.8× 64 0.2× 195 1.0× 153 1.1× 29 0.3× 9 368
Hein Hustinx Switzerland 16 112 0.3× 78 0.3× 411 2.0× 41 0.3× 117 1.2× 31 503
Rita Maria Pinto Italy 10 100 0.3× 46 0.2× 153 0.8× 76 0.5× 45 0.5× 19 291
Venina Marcela Dominical Brazil 11 125 0.4× 116 0.4× 92 0.5× 24 0.2× 27 0.3× 21 325

Countries citing papers authored by Erica B. Esrick

Since Specialization
Citations

This map shows the geographic impact of Erica B. Esrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica B. Esrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica B. Esrick more than expected).

Fields of papers citing papers by Erica B. Esrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erica B. Esrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica B. Esrick. The network helps show where Erica B. Esrick may publish in the future.

Co-authorship network of co-authors of Erica B. Esrick

This figure shows the co-authorship network connecting the top 25 collaborators of Erica B. Esrick. A scholar is included among the top collaborators of Erica B. Esrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erica B. Esrick. Erica B. Esrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Esrick, Erica B., et al.. (2024). β-Thalassemia minor is associated with high rates of worsening anemia in pregnancy. Blood. 145(6). 648–651. 1 indexed citations
3.
Chapman, Michael Spencer, Alyssa Cull, Marioara F. Ciuculescu, et al.. (2023). Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease. Nature Medicine. 29(12). 3175–3183. 27 indexed citations
4.
Kao, Pei‐Chi, Emma Morris, Amy Federico, et al.. (2023). Patient and Parent-Reported Outcomes Post-Treatment with Shmir-Based Lentiviral Gene Therapy for Sickle Cell Disease. Blood. 142(Supplement 1). 3750–3750. 1 indexed citations
5.
Long, Kristin A., Christina M. Amaro, Arvin Garg, et al.. (2023). Bidirectional processes linking social determinants of health and pediatric sickle cell anemia management: A qualitative study. Pediatric Blood & Cancer. 70(10). e30539–e30539. 5 indexed citations
6.
Hebert, Nicolas, Erica B. Esrick, Marioara F. Ciuculescu, et al.. (2023). Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling. Nature Communications. 14(1). 5850–5850. 10 indexed citations
7.
Walters, Mark C., Angela R. Smith, Gary J. Schiller, et al.. (2021). Updated Results of a Phase 1/2 Clinical Study of Zinc Finger Nuclease-Mediated Editing of BCL11A in Autologous Hematopoietic Stem Cells for Transfusion-Dependent Beta Thalassemia. Blood. 138(Supplement 1). 3974–3974. 15 indexed citations
8.
Esrick, Erica B., Nicolas Hebert, Giuseppe Di Caprio, et al.. (2021). Effects of BCL11A Shmir-Induced Post-Transcriptional Silencing on Hemoglobin Polymer Inhibition in Single Red Blood Cells at Physiologic Oxygen Tension. Blood. 138(Supplement 1). 964–964. 3 indexed citations
9.
Esrick, Erica B., et al.. (2021). β-Thalassemia: evolving treatment options beyond transfusion and iron chelation. Hematology. 2021(1). 600–606. 20 indexed citations
10.
Hebert, Nicolas, Erica B. Esrick, Myriam Armant, et al.. (2021). Effects of BCL11A Shmir-Induced Post-Transcriptional Silencing on Distributions of HbF in Single-RBCs and Reticulocytes. Blood. 138(Supplement 1). 967–967. 1 indexed citations
11.
Cull, Alyssa, Michael Spencer Chapman, Marioara F. Ciuculescu, et al.. (2021). Clonal Tracking By Whole Genome Sequencing Permits Comprehensive Mapping of the Genomic Landscape in Pre- and Post-Gene Therapy Sickle Cell Patients. Blood. 138(Supplement 1). 559–559. 4 indexed citations
13.
Esrick, Erica B., John Manis, Heather Daley, et al.. (2018). Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients. Blood Advances. 2(19). 2505–2512. 59 indexed citations
14.
Esrick, Erica B. & Daniel E. Bauer. (2018). Genetic therapies for sickle cell disease. Seminars in Hematology. 55(2). 76–86. 32 indexed citations
15.
Rowe, R. Grant & Erica B. Esrick. (2015). Howell-Jolly–like bodies in neutrophils. Blood. 125(17). 2729–2729. 3 indexed citations
16.
Lee, Sang Hong, Prasanna Ananth, Theonia K. Boyd, Erica B. Esrick, & Heung Bae Kim. (2014). Successful surgical thrombectomy for neonatal IVC and bilateral renal vein thrombosis. Journal of Pediatric Surgery Case Reports. 2(4). 176–179. 4 indexed citations
17.
Xu, Jian, Cong Peng, Vijay G. Sankaran, et al.. (2011). Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing. Science. 334(6058). 993–996. 246 indexed citations
18.
Xu, Jian, Vijay G. Sankaran, Erica B. Esrick, Benjamin L. Ebert, & Stuart H. Orkin. (2010). Reactivation of Silenced Human HbF In Adult Mice by Inactivation of BCL11A. Blood. 116(21). 643–643. 1 indexed citations
19.
Subramanian, Manju L., Jeffrey S. Heier, Erica B. Esrick, et al.. (2006). Preoperative Visual Acuity as a Prognostic Indicator for Laser Treatment of Macular Edema Due to Branch Retinal Vein Occlusion. Ophthalmic surgery, lasers & imaging retina. 37(6). 462–467. 9 indexed citations
20.
Esrick, Erica B., Manju L. Subramanian, Jeffrey S. Heier, et al.. (2005). Multiple laser treatments for macular edema attributable to branch retinal vein occlusion. American Journal of Ophthalmology. 139(4). 653–657. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026